Vera Therapeutics Inc (VERA)

Vera Therapeutics Inc stock is traded at $31.97, with a volume of 1,878,498. It is up +4.10% in the last 24 hours and up +5.10% over the past month. Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.